Plus, U.S. sales of previously owned homes surged the most on record in July, Deere delivered an earnings beat, and Tesla shares surged past $2,000.
Read MoreAnalysts see massive upside ahead for these 3 stocks.
Read MorePlus, there’s fresh hope on the stimulus front, Target delivered a blowout earnings report, and Johnson & Johnson is buying Momenta Pharmaceuticals.
Read MoreBuy Price: $6.50 or better Sell Price: TradersPro Sell Signal Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies. The company develops human immunoglobulin isotype G4 monoclonal antibodies, including SRF231 inhibiting CD47; NZV930 inhibiting CD73; SRF617 inhibiting CD39; SRF388 targeting interleukin 27; and SRF813 targeting CD112R. It also develops various […]
Read MorePlus, Senate Republicans are planning to introduce a scaled back stimulus bill as the standoff with Democrats over a new virus relief plan continues, Quest Diagnostics sped up its coronavirus testing turnaround time, and three big retailers reported earnings.
Read MoreBuy Price: $4.50 or better Sell Price: TradersPro Sell Signal Genprex, Inc. operates as a clinical-stage gene therapy company. The company engages in developing technologies for cancer patients based upon a proprietary technology platform. Its platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then […]
Read MorePlus, the FDA granted Yale University’s saliva-based coronavirus test emergency use authorization, Sanofi is buying Principia Biopharma, and Amazon is mulling an investment in Rackspace Technologies.
Read MoreBuy Price: $2.25 or better Sell Price: TradersPro Sell Signal PAVmed Inc. operates as a medical device company in the United States. The company’s lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous […]
Read MorePlus, It just got even more unlikely Congress will come to agreement on the next coronavirus relief bill before September, Novavax reached a deal with the U.K. for 60 million doses of its coronavirus vaccine, and Simon Property Group is teaming up with Authentic Brands Group to take over Lucky Brand.
Read MoreTrade Setup Buy Target: $22.94 Sell Target: $26.07 Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is developing small molecule drug candidates primarily engineered to increase muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac […]
Read MoreBuy Price: $8.00 or better Sell Price: TradersPro Sell Signal Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and completed […]
Read MorePlus, Novavax signed a deal with SK Bioscience to manufacture the antigen component of its COVID-19 vaccine candidate, Apple is reportedly preparing bundles of its digital services, and Tapestry shares are down after reporting earnings.
Read MoreTrade Setup Buy Target: $1.84 Sell Target: $2.22 Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, is being developed as a rapidly acting, oral agent for the treatment of depression, neuropathic pain, and/or […]
Read MorePlus, China wants TikTok and WeChat to be on the agenda in upcoming trade talks with the U.S., the U.S. government will purchase at least 100 million doses of Moderna’s coronavirus vaccine, and Stein Mart just became the latest retailer to declare bankruptcy.
Read MorePlus, Russia’s Putin claims the country has approved the world’s first coronavirus vaccine, Boeing said cancellations outpaced new sales for the sixth straight month in July, and Nikola shares surged after landing a garbage trucks deal.
Read More